Position in DHR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,058,497
-$39,097 QoQ
Shares Held
5,557
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,080
of 2,098 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AlphaCore Capital LLC holds $13,485,326 across 13 Diagnostics & Research names. DHR ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,091 | $5,059,223 | |
| 2 | DGX |
Quest Diagnostics Inc
|
9,371 | $1,986,183 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,066 | $1,087,625 | |
| 4 | DHR |
Danaher Corp /De/
This page
|
5,557 | $1,058,497 | |
| 5 | ILMN |
Illumina, Inc.
|
4,750 | $835,192 | |
| 6 | A |
Agilent Technologies, Inc.
|
5,360 | $711,968 | |
| 7 | LH |
Labcorp Holdings Inc.
|
2,435 | $681,800 | |
| 8 | NTRA |
Natera, Inc.
|
2,139 | $580,631 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,058,497 | 5,557 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,097,594 | 5,789 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,343,302 | 5,868 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,031,943 | 5,205 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,350,185 | 6,835 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,002,030 | 9,766 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $833,725 | 3,632 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $1,082,887 | 3,895 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $818,508 | 3,276 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $283,681 | 1,136 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||